Vauix Milien, France

Herve Dumas

This inventor holds 8 USPTO granted patents, plus 1 CIPO patent. Top assignees: Lipha, Lyonnaise Industrielle Pharmaceutique, Lipha, Lyonnaise Industrille Pharmaceutique, Merck Patent Gesellschaft MIT. Active years: 1985-2003.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Herve Dumas. Retrieved from https://idiyas.com/inventor/herve-dumas

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

 

Average Co-Inventor Count = 4.3

ph-index = 2

Forward Citations = 113(Granted Patents)


Location History:

  • Villefontaine, FR (1985 - 1993)
  • Vaulx-Milieu, FR (1996 - 1999)
  • Vaulx Millien, FR (2000)
  • Vauix Milien, FR (2003)

Company Filing History:


Years Active: 1985-2003

Loading Chart...
Loading Chart...
8 patents (USPTO):Explore Patents

Title: Inventor Herve Dumas

Introduction: Herve Dumas is a renowned inventor hailing from Vauix Milien, France, known for his groundbreaking contributions to the field of technology and innovation.

Latest Patents: Herve Dumas holds several patents in various technological domains, showcasing his continuous dedication to pushing the boundaries of innovation.

Career Highlights: Throughout his illustrious career, Herve Dumas has been instrumental in developing cutting-edge solutions that have revolutionized industries and improved the lives of many.

Collaborations: Herve Dumas has collaborated with leading tech companies and research institutions, fostering a culture of innovation and knowledge sharing to drive progress in the field.

Conclusion: In conclusion, Herve Dumas stands as a visionary inventor whose work continues to inspire and shape the future of technology and innovation.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…